Arterial hypertension

医学 动态血压 重症监护医学 血管紧张素受体阻滞剂 螺内酯 心脏病学 内科学 血压 疾病 回廊的 血管紧张素转换酶 药物治疗 药丸 药理学 心力衰竭
作者
Sofie Brouwers,Isabella Sudano,Yoshihiro Kokubo,Elisabeth M. Sulaica
出处
期刊:The Lancet [Elsevier]
卷期号:398 (10296): 249-261 被引量:238
标识
DOI:10.1016/s0140-6736(21)00221-x
摘要

Arterial hypertension is the most important contributor to the global burden of disease; however, disease control remains poor. Although the diagnosis of hypertension is still based on office blood pressure, confirmation with out-of-office blood pressure measurements (ie, ambulatory or home monitoring) is strongly recommended. The definition of hypertension differs throughout various guidelines, but the indications for antihypertensive therapy are relatively similar. Lifestyle adaptation is absolutely key in non-pharmacological treatment. Pharmacologically, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, calcium channel blockers, and diuretics are the first-line agents, with advice for the use of single-pill combination therapy by most guidelines. As a fourth-line agent, spironolactone should be considered. The rapidly evolving field of device-based therapy, especially renal denervation, will further broaden therapeutic options. Despite being a largely controllable condition, the actual rates of awareness, treatment, and control of hypertension are disappointingly low. Further improvements throughout the process of patient screening, diagnosis, treatment, and follow-up need to be urgently addressed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
by完成签到 ,获得积分20
刚刚
研友_EZ1KkL完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
1秒前
2秒前
0009987完成签到,获得积分10
2秒前
2秒前
ding应助月不笑采纳,获得10
2秒前
suohaiyun发布了新的文献求助10
3秒前
小二郎应助科研通管家采纳,获得10
3秒前
3秒前
小宋发布了新的文献求助10
3秒前
大个应助科研通管家采纳,获得30
3秒前
吃人陈发布了新的文献求助10
3秒前
斯文败类应助科研通管家采纳,获得10
3秒前
烟花应助科研通管家采纳,获得10
3秒前
liuchengrui应助科研通管家采纳,获得10
3秒前
情怀应助科研通管家采纳,获得10
3秒前
3秒前
科研通AI6应助科研通管家采纳,获得10
3秒前
星辰大海应助科研通管家采纳,获得10
3秒前
kagaminelen完成签到,获得积分10
3秒前
爆米花应助科研通管家采纳,获得10
3秒前
量子星尘发布了新的文献求助10
3秒前
科研通AI6应助科研通管家采纳,获得10
3秒前
科目三应助科研通管家采纳,获得10
3秒前
共享精神应助科研通管家采纳,获得10
3秒前
科研通AI6应助科研通管家采纳,获得10
3秒前
BowieHuang应助科研通管家采纳,获得10
3秒前
深情安青应助科研通管家采纳,获得10
4秒前
Owen应助科研通管家采纳,获得10
4秒前
mengtingmei应助科研通管家采纳,获得10
4秒前
JamesPei应助科研通管家采纳,获得10
4秒前
Lucas应助科研通管家采纳,获得10
4秒前
xdd完成签到,获得积分10
4秒前
小蘑菇应助科研通管家采纳,获得10
4秒前
星辰大海应助科研通管家采纳,获得10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5718762
求助须知:如何正确求助?哪些是违规求助? 5254117
关于积分的说明 15287024
捐赠科研通 4868786
什么是DOI,文献DOI怎么找? 2614471
邀请新用户注册赠送积分活动 1564338
关于科研通互助平台的介绍 1521791